|
1
|
The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.
|
Pancreas
|
2010
|
2.84
|
|
2
|
90Y-edotreotide for metastatic carcinoid refractory to octreotide.
|
J Clin Oncol
|
2010
|
1.49
|
|
3
|
RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.
|
Cancer
|
2006
|
1.01
|
|
4
|
Management of neuroendocrine tumors in children, adolescents, and young adults.
|
J Pediatr Hematol Oncol
|
2012
|
0.98
|
|
5
|
Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells.
|
Exp Eye Res
|
2004
|
0.93
|
|
6
|
A DOTA-peptide conjugate by copper-free click chemistry.
|
Bioorg Med Chem Lett
|
2010
|
0.93
|
|
7
|
Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior.
|
Pancreas
|
2010
|
0.92
|
|
8
|
Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors.
|
J Nucl Med
|
2010
|
0.88
|
|
9
|
Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling.
|
Surgery
|
2012
|
0.87
|
|
10
|
Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors.
|
Surgery
|
2013
|
0.87
|
|
11
|
Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide.
|
J Immunol
|
2006
|
0.86
|
|
12
|
MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.
|
J Nucl Med
|
2005
|
0.85
|
|
13
|
Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
|
Pediatr Blood Cancer
|
2011
|
0.84
|
|
14
|
ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.
|
J Surg Res
|
2007
|
0.83
|
|
15
|
Pancreastatin predicts survival in neuroendocrine tumors.
|
Ann Surg Oncol
|
2014
|
0.83
|
|
16
|
Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors.
|
Pancreas
|
2013
|
0.83
|
|
17
|
Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.
|
Bioorg Med Chem Lett
|
2011
|
0.82
|
|
18
|
The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation.
|
J Mol Neurosci
|
2008
|
0.81
|
|
19
|
2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells.
|
Cancer Biol Ther
|
2010
|
0.81
|
|
20
|
Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model.
|
J Nucl Med
|
2006
|
0.80
|
|
21
|
A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon.
|
Regul Pept
|
2003
|
0.80
|
|
22
|
A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
|
J Pharmacol Exp Ther
|
2003
|
0.80
|
|
23
|
Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging.
|
Clin Cancer Res
|
2004
|
0.80
|
|
24
|
Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors.
|
J Pediatr Hematol Oncol
|
2005
|
0.80
|
|
25
|
G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.
|
Acta Neuropathol Commun
|
2013
|
0.79
|
|
26
|
Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies.
|
Pediatr Blood Cancer
|
2008
|
0.79
|
|
27
|
Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors.
|
Oncologist
|
2008
|
0.78
|
|
28
|
VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice.
|
Regul Pept
|
2003
|
0.78
|
|
29
|
Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.
|
Regul Pept
|
2002
|
0.77
|
|
30
|
Neuroendocrine tumors in children and young adults: rare or not so rare.
|
Endocrinol Metab Clin North Am
|
2011
|
0.77
|
|
31
|
Atypical teratoid/rhabdoid tumor case report: treatment with surgical excision, radiation therapy, and alternative medicines.
|
J Neurooncol
|
2005
|
0.76
|
|
32
|
Expression of somatostatin receptors 1 and 2 in human choroid plexus and arachnoid granulations: implications for idiopathic intracranial hypertension.
|
Arch Ophthalmol
|
2002
|
0.75
|